Feng Min, Zhao Yuhui, Li Hongmei
Department of Gynecology, Shanxi Children's Hospital Shanxi Maternal and Child Health Hospital Taiyuan 030001, Shanxi, China.
Department of Obstetrics and Gynecology, Shanxi Children's Hospital Shanxi Maternal and Child Health Hospital Taiyuan 030001, Shanxi, China.
Am J Transl Res. 2024 Nov 15;16(11):6718-6726. doi: 10.62347/JPHM2503. eCollection 2024.
To evaluate the clinical efficacy of hysteroscopy in the treatment of molar pregnancy and postoperative residual tissue.
This retrospective study involved 68 patients who underwent treatment for molar pregnancy in Shanxi Children's Hospital Shanxi Maternal and Child Health Hospital from April 2020 to May 2022. Based on intervention methods, patients were divided into a conventional group (n=33) and a hysteroscopy group (n=35). The effects of different treatment methods on perioperative outcomes, prognosis, serum factor levels and complication rates were compared between the two groups.
The comparison of general data, including age, gestational times, the number of patients with a cleared uterus, and the time interval from the last menstruation to hysteroscopic surgery, showed no significant differences between the two groups (all P > 0.05). The operation duration and menstrual recovery time of the hysteroscopy group were significantly shorter than those of the conventional group, and the intraoperative blood loss was significantly less than that in the conventional group (all P < 0.05). After surgery, endometrial thickness in hysteroscopy group was significantly thinner than that in conventional group (P < 0.05), though there was no significant difference in uterine adhesion rates (P > 0.05). Before surgery, there was no significant difference in serum factor levels between the two groups (P > 0.05). After surgery, the levels of β-human chorionic gonadotropin (β-HCG), creatine kinase (CK), trend factor interleukin-10 (CXCL10), and placental growth factor (PlGF) in the hysteroscopic group were all lower than those in the conventional group (all P < 0.05), while pregnancy-associated plasma protein-A (PAPP-A) was higher. The cure rate in the hysteroscopy group was significantly higher, while the total incidence of complications was significantly lower than those in the conventional group (all P < 0.05).
Hysteroscopic treatment for molar pregnancy effectively removes lesions, reduces the treatment load, and provides the potential to preserve fertility function.
评估宫腔镜在治疗葡萄胎及术后残留组织中的临床疗效。
本回顾性研究纳入了2020年4月至2022年5月在山西省儿童医院山西省妇幼保健院接受葡萄胎治疗的68例患者。根据干预方法,将患者分为传统组(n = 33)和宫腔镜组(n = 35)。比较两组不同治疗方法对围手术期结局、预后、血清因子水平和并发症发生率的影响。
两组患者的年龄、孕周、清宫患者数量以及末次月经至宫腔镜手术的时间间隔等一般资料比较,差异均无统计学意义(均P > 0.05)。宫腔镜组的手术时间和月经恢复时间明显短于传统组,术中出血量明显少于传统组(均P < 0.05)。术后,宫腔镜组的子宫内膜厚度明显薄于传统组(P < 0.05),但子宫粘连率差异无统计学意义(P > 0.05)。术前,两组血清因子水平差异无统计学意义(P > 0.05)。术后,宫腔镜组的β-人绒毛膜促性腺激素(β-HCG)、肌酸激酶(CK)、趋化因子白细胞介素-10(CXCL10)和胎盘生长因子(PlGF)水平均低于传统组(均P < 0.05),而妊娠相关血浆蛋白-A(PAPP-A)则较高。宫腔镜组的治愈率明显更高,而并发症总发生率明显低于传统组(均P < 0.05)。
宫腔镜治疗葡萄胎能有效清除病灶,减轻治疗负担,并具有保留生育功能的潜力。